The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ritger, P. L., & Peppas, N. A. (1987) · Journal of Controlled Release · doi:10.1016/0168-3659(87)90035-6 · Cited by 4,064
Nanosuspensions as particulate drug formulations in therapy
Müller, R. H., Jacobs, C., & Kayser, O. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00118-6 · Cited by 1,370
Biodegradable nanoparticles for drug delivery and targeting
Hans, M. L., & Lowman, A. M. (2002) · Current Opinion in Solid State and Materials Science · doi:10.1016/s1359-0286(02)00117-1 · Cited by 1,324
Mohanraj, V. J., & Chen, Y. (2007) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v5i1.14634 · Cited by 1,217
Fan, W., Yan, W., Xu, Z., & Ni, H. (2012) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2011.09.042 · Cited by 929
Calvo, P., Remuñan-López, C., Vila-Jato, J. L., & Alonso, M. J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012128907225 · Cited by 817
Design of biodegradable particles for protein delivery
Vila, A., Sánchez, A., Tobı́o, M., Calvo, P., & Alonso, M. J. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00486-2 · Cited by 620
Nanoparticle Technology for Drug Delivery Across the Blood-Brain Barrier
Lockman, P. R., Mumper, R. J., Khan, M. A., & Allen, D. D. (2002) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120001481 · Cited by 592
Effect of chitosan on epithelial permeability and structure
Dodane, V (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00030-7 · Cited by 578
MOTWANI, S., CHOPRA, S., TALEGAONKAR, S., KOHLI, K., AHMAD, F., & KHAR, R. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.09.009 · Cited by 557
Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate
Wu, Y., Yang, W., Wang, C., Hu, J., & Fu, S. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.01.042 · Cited by 517
Synthesis and characterization of chitosan–poly(acrylic acid) nanoparticles
Hu, Y., Jiang, X., Ding, Y., Ge, H., Yuan, Y., & Yang, C. (2002) · Biomaterials · doi:10.1016/s0142-9612(02)00071-6 · Cited by 513
Drug delivery to the central nervous system: a review.
Misra, A. R., Ganesh, S. D., Shahiwala, A., & Shah, S. P. (2003) · PubMed · Cited by 441
Intranasal nanoemulsion based brain targeting drug delivery system of risperidone
Kumar, M., Misra, A., Babbar, A. K., Mishra, A. K., Mishra, P., & Pathak, K. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.03.029 · Cited by 435
Self-citationAvadi, M. R., Sadeghi, A. M. M., Mohammadpour, N., Abedin, S., Atyabi, F., Dinarvand, R., & Rafiee-Tehrani, M. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2009.04.007 · Cited by 400
Borchard, G., Lueβen, H. L., de Boer, A. G., Verhoef, J. C., Lehr, C.-M., & Junginger, H. E. (1996) · Journal of Controlled Release · doi:10.1016/0168-3659(95)00146-8 · Cited by 393
Drug delivery to the central nervous system: A review
Tamargo, R. J., & Brem, H. (1992) · Neurosurgery Quarterly · Cited by 369
Bioadhesive chitosan nanoparticles: Preparation and characterization
Dudhani, A. R., & Kosaraju, S. L. (2010) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2010.02.026 · Cited by 335
Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting
Wang, X., Chi, N., & Tang, X. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.07.005 · Cited by 305
Chitosan nanoparticles loaded with dorzolamide and pramipexole
Papadimitriou, S. A., Bikiaris, D. Ν., Avgoustakis, K., Karavas, E., & Georgarakis, M. (2007) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2007.11.007 · Cited by 290
Zhang, Q., Jiang, X., Jiang, W., Lu, W., Su, L., & Shi, Z. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.01.039 · Cited by 286
Chitosan nanoparticles as a new delivery system for the anti-Alzheimer drug tacrine
Wilson, B., Samanta, M. K., Santhi, K., Kumar, K. P. S., Ramasamy, M., & Suresh, B. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2009.04.001 · Cited by 244
Sadeghi, A. M. M., Dorkoosh, F. A., Avadi, M. R., Saadat, P., Rafiee-Tehrani, M., & Junginger, H. E. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.11.052 · Cited by 238
Joshi, S. A., Chavhan, S. S., & Sawant, K. K. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.07.007 · Cited by 235
Tosi, G., Costantino, L., Rivasi, F., Ruozi, B., Leo, E., Vergoni, A. V., Tacchi, R., Bertolini, A., Vandelli, M. A., & Forni, F. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.022 · Cited by 234
Neurotherapeutic applications of nanoparticles in Alzheimer’s disease
Sahni, J. K., Doggui, S., Ali, J., Baboota, S., Dao, L., & Ramassamy, C. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.033 · Cited by 219
Ge, H., Hu, Y., Jiang, X., Cheng, D., Yuan, Y., Bi, H., & Yang, C. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10143 · Cited by 199
Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution
Vergoni, A. V., Tosi, G., Tacchi, R., Vandelli, M. A., Bertolini, A., & Costantino, L. (2009) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2009.02.005 · Cited by 150
Ray, B., & Lahiri, D. K. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.06.012 · Cited by 150
Khan, S., Patil, K., Bobade, N. N., Yeole, P. G., & Gaikwad, R. V. (2009) · Journal of drug targeting · doi:10.3109/10611860903386938 · Cited by 142
Preparation and in vitro evaluation of chitosan nanoparticles containing a caspase inhibitor
Aktaş, Y., Andrieux, K., Alonso, M. J., Calvo, P., Gürsoy, R. N., Couvreur, P., & Çapan, Y. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.03.027 · Cited by 135
Porporatto, C., Bianco, I. D., & Correa, S. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0904541 · Cited by 126
Al-Ghananeem, A. M., Saeed, H. M., Florence, R. L., Yokel, R. A., & Malkawi, A. H. (2009) · Journal of drug targeting · doi:10.3109/10611860903483396 · Cited by 116
Löbenberg, R. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00105-3 · Cited by 109
Kosasa, T., Kuriya, Y., Matsui, K., & Yamanishi, Y. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00741-4 · Cited by 72
Amini, H., & Ahmadiani, A. (2010) · Europe PMC (PubMed Central) · Cited by 18
Cited by
Evaluation of intranasal delivery route of drug administration for brain targeting
Erdő, F., Bors, L. A., Farkas, D., Bajza, Á., & Gizurarson, S. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.10.009 · Cited by 744
Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases
Furtado, D., Björnmalm, M., Ayton, S., Bush, A. I., Kempe, K., & Caruso, F. (2018) · Advanced Materials · doi:10.1002/adma.201801362 · Cited by 708
Agrawal, M., Saraf, S., Saraf, S., Antimisiaris, S. G., Chougule, M. B., Shoyele, S. A., & Alexander, A. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.05.011 · Cited by 630
Chitosan in nasal delivery systems for therapeutic drugs
Casettari, L., & Illum, L. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.003 · Cited by 444
Insights into Direct Nose to Brain Delivery: Current Status and Future Perspective
Mittal, D., Ali, A., Md, S., Baboota, S., Sahni, J. K., & Ali, J. (2014) · Drug Delivery · doi:10.3109/10717544.2013.838713 · Cited by 359
Self-citation
Metadata
- Authors
- Fazil, M., Md, S., Haque, S., Kumar, M., Baboota, S., Sahni, J. K., & Ali, J.
- Venue
- European Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2012-08
- Volume
- 47
- Issue
- 1
- Pages
- 6-15
- ISSN
- 0928-0987 (ISSN-L)
- OpenAlex
- W2014202811
- Cited by
- 379
- References
- 36
- FWCI
- 10.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.